Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: A randomized, double-blind, placebo-controlled pharmacodynamic study

R. S. Choung, G. R. Locke, D. D. Francis, D. Katzka, P. J. Winkle, W. C. Orr, M. D. Crowell, K. Devault, W. S. Harmsen, A. R. Zinsmeister, N. J. Talley

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: A randomized, double-blind, placebo-controlled pharmacodynamic study'. Together they form a unique fingerprint.

Medicine & Life Sciences